ID26730A - Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein - Google Patents

Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein

Info

Publication number
ID26730A
ID26730A IDW20002684A ID20002684A ID26730A ID 26730 A ID26730 A ID 26730A ID W20002684 A IDW20002684 A ID W20002684A ID 20002684 A ID20002684 A ID 20002684A ID 26730 A ID26730 A ID 26730A
Authority
ID
Indonesia
Prior art keywords
scd14
lait
proteins
induction
protein
Prior art date
Application number
IDW20002684A
Other languages
English (en)
Inventor
Michael H Julius
Dominik Filipp
Original Assignee
Gemma Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemma Biotechnology Ltd filed Critical Gemma Biotechnology Ltd
Publication of ID26730A publication Critical patent/ID26730A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IDW20002684A 1998-05-27 1999-05-27 Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein ID26730A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8688498P 1998-05-27 1998-05-27

Publications (1)

Publication Number Publication Date
ID26730A true ID26730A (id) 2001-02-01

Family

ID=22201526

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002684A ID26730A (id) 1998-05-27 1999-05-27 Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein

Country Status (14)

Country Link
US (1) US7592310B2 (id)
EP (1) EP1080111B1 (id)
JP (1) JP2002516339A (id)
CN (1) CN1322214A (id)
AU (1) AU771448B2 (id)
BR (1) BR9910725A (id)
CA (1) CA2328134A1 (id)
CZ (1) CZ20004256A3 (id)
HK (1) HK1041892A1 (id)
HU (1) HUP0101987A3 (id)
ID (1) ID26730A (id)
IL (1) IL139339A0 (id)
PL (1) PL345208A1 (id)
WO (1) WO1999061468A2 (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347069A1 (en) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gastrointestinal tract disorder
AU2001244711A1 (en) * 2000-03-31 2001-10-08 Mochida Pharmaceutical Co., Ltd. Tlr/cd14 binding inhibitor
CN1787741B (zh) 2003-05-15 2011-08-17 唐纳士公司 用于预防和治疗败血症的方法与组合物
JP4040666B2 (ja) * 2004-05-11 2008-01-30 持田製薬株式会社 新規可溶性ｃｄ１４抗原
WO2009095916A2 (en) * 2008-01-29 2009-08-06 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Cd14 and peptides thereof for protection of cells against cell death
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
WO2010125565A2 (en) 2009-04-27 2010-11-04 Hadasit Medical Research Services And Development Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
DK2605791T3 (en) 2010-08-17 2017-06-19 Immuron Ltd ANTI-LPS ENHANCED IMMUNOGLOBULIN PREPARATION FOR USE IN TREATMENT AND / OR PROPHYLAXY OF A PATHOLOGICAL DISORDER
RU2723554C2 (ru) * 2011-05-19 2020-06-16 Мотида Фармасьютикал Ко., Лтд. Диагностика инфекционного заболевания дыхательных путей с использованием образцов крови

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
EP0485430B1 (en) * 1989-08-01 1998-09-16 The Scripps Research Institute Methods and compositions for ameliorating the symptoms of sepsis
WO1993019772A1 (en) * 1992-04-06 1993-10-14 North Shore University Hospital Research Corporation A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
CA2163976C (en) * 1993-05-28 2010-06-29 Didier J. Leturcq Methods and compositions for inhibiting cd14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
JPH10512142A (ja) * 1994-12-30 1998-11-24 アムジエン・インコーポレーテツド 抗炎症性ｃｄ１４ポリペプチド
WO1996032418A1 (en) 1995-04-13 1996-10-17 Laboratoires Om S.A. Anti-cd14 antibodies for use in the induction of il-10 secretion
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CZ20004256A3 (cs) 2001-09-12
JP2002516339A (ja) 2002-06-04
HUP0101987A3 (en) 2010-01-28
PL345208A1 (en) 2001-12-03
HUP0101987A2 (hu) 2001-09-28
CN1322214A (zh) 2001-11-14
AU771448B2 (en) 2004-03-25
EP1080111A2 (en) 2001-03-07
WO1999061468A2 (en) 1999-12-02
US20040259795A1 (en) 2004-12-23
EP1080111B1 (en) 2012-07-25
BR9910725A (pt) 2001-01-30
AU4025899A (en) 1999-12-13
WO1999061468A3 (en) 2000-04-06
HK1041892A1 (zh) 2002-07-26
CA2328134A1 (en) 1999-12-02
US7592310B2 (en) 2009-09-22
IL139339A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
NO961796D0 (no) Rekombinante fedme (ob) proteiner
FI974429L (fi) Suspendoituja peptidi/proteiinivalmisteita
DE69434520D1 (de) Biotinylierung von proteinen
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
NO20001240D0 (no) Kay-A immunsystemprotein
FI965032A7 (fi) Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita
FI973162A0 (fi) Liikalihavuutta vastustavia proteiineja
DE69839603D1 (de) Zierenden proteins
BR9709529A (pt) Fragmentos de leptina (proteína ob)
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
FI964549L (fi) Monisylinteripipetti
DK0988861T3 (da) Stabiliserede proteinpræparater
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ZA9811316B (en) Novel hepatitis C virus NS5B protein
ID26730A (id) Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein
NO971448D0 (no) Anti-Fas rekombinante antistoffer og DNA derfor
ID21034A (id) Protein kinase dan penggunaannya
FI961584L (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
ID19257A (id) Protein-protein anti-obesitas
ATE295417T1 (de) Angiostatin-bindendes protein
EP0821694A4 (en) CONOTOXIN PEPTIDE
ID26903A (id) Metode untuk menghasilkan protein terhidrolisis
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
FI980782L (fi) Epiteelisoluihin sitoutuva proteiinialue ja sitä koodaava DNA-sekvenssi
EP1127066A4 (en) MODIFIED PROTEINS